~~<i id='0A61FA8E70'><strike id='0A61FA8E70'><tt id='0A61FA8E70'><pre id='0A61FA8E70'></pre></tt></strike></i>~~

Home» leisure time» fashion

fashion

author：hotspot 2025-08-06 00:47:50 Page View：39566

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Galapagos to make CAR
Next article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

comprehensive

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

As H5N1 spreads in cows, experts warn against drinking raw milk

RobertF.Bukaty/APScientistswhoknowaboutthetypesofpathogens—E.coliandSalmonellaamongthem— thatcanbetr

New air purifier tech could be key to improving indoor air quality

AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

Novo Nordisk testing Wegovy against alcohol

AdobeNovoNordiskwilltestwhetheritsGLP-1drugscanhelppeoplewithalcohol-associatedliverdisease,and,aspa

WSS

fashion

fashion

explore

comprehensive

Novo Nordisk testing Wegovy against alcohol